ArticleAmerican journal of respiratory cell and molecular biology2022

Mesenchymal Stem Cell-derived Nanovesicles as a Credible Agent for Therapy of Pulmonary Hypertension.

Li Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.